Keyphrases
COVID-19
100%
Clinical Outcomes
100%
Clinical Characteristics
100%
Retrospective Cohort Study
100%
Chronic Hepatitis B Virus Infection
100%
Hepatitis B Virus Reactivation
83%
Hepatitis B Surface Antigen (HBsAg)
66%
Hepatitis B Virus
50%
Anti-HBc
50%
HBsAg-negative
33%
Hepatitis Flare
33%
Antiretroviral Therapy
16%
High Dose
16%
Concomitant Infection
16%
Serology
16%
Infectious Diseases
16%
Retrospective Observational Study
16%
Hospitalized Patients
16%
Major Risk Factors
16%
Major Risk
16%
Overall Rate
16%
Corticosteroid Treatment
16%
Predictive Factors
16%
Prevalence Factors
16%
Overall Risk
16%
Monocentric
16%
Immune-suppressive
16%
Suppressive Therapy
16%
HBsAg-positive
16%
Admitted Patients
16%
Hepatitis B Infection
16%
Serological Status
16%
Protective Elements
16%
HBeAg Seroconversion
16%
Severe Hepatitis B
16%
Systemic Corticosteroid Therapy
16%
Medicine and Dentistry
COVID-19
100%
Retrospective Cohort Study
100%
Hepatitis B Virus
100%
Chronic Hepatitis B
100%
Hepatitis B Antigen
62%
Virus Reactivation
62%
Hepatitis B Core Antibody
37%
Hepatitis B Antibody
37%
Corticosteroid Therapy
25%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Antiviral Therapy
12%
Infection
12%
Drug Megadose
12%
Prevalence
12%
Observational Study
12%
Concurrent Infection
12%
Predictive Factor
12%
Hepatitis B
12%
Infectious Disease
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Hepatitis B Virus
100%
Chronic Hepatitis B
100%
Coronavirinae
100%
Diseases
100%
Hepatitis B Antigen
62%
Hepatitis B Core Antibody
37%
Hepatitis B Antibody
37%
Infection
12%
Prevalence
12%
Concurrent Infection
12%
Observational Study
12%
Hepatitis B
12%
Antiviral Therapy
12%
SARS Coronavirus
12%